CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Nicotine (transdermal)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02350335
NCT02350335N/ACompleted
CompareCT.gov

Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid Hemorrhage

Oslo University Hospital·interventional·Posted Jan 29, 2015·Updated Apr 12, 2016

In Brief

A clinical study evaluating Nicotine (transdermal) for Aneurysmal Subarachnoid Hemorrhage. Completed, enrolled 200 participants across 1 site.

Detailed Summary

All patients with acute aneurysmal hemorrhage are treated in accordance with our institutional protocol. After securing of the aneurysm, some smokers with acute aneurysmal hemorrhage are randomly assigned to transdermal nicotine replacement (NRT). The short- and long-term effect of NRT will be studied comparing non-smokers, smokers without NRT and smokers with NRT.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAneurysmal Subarachnoid Hemorrhage
CountriesNorway
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 29, 2015
Enrollment StartJan 1, 2011
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 11.4 years ago

Interventions

Nicotine (transdermal)drug

Application of transdermal nicotine replacement in smokers with acute aneurysmal hemorrhage